Gender effect in the ITALUNG screening trial. A comparison with UKLS and other trials
Lancet Reg Health Eur
.
2022 Jan 1:13:100300.
doi: 10.1016/j.lanepe.2021.100300.
eCollection 2022 Feb.
Authors
Donella Puliti
1
,
Giulia Picozzi
1
,
Giuseppe Gorini
1
,
Laura Carrozzi
2
,
Mario Mascalchi
1
3
Affiliations
1
Oncological Network, Prevention and Research Institute (ISPRO), Florence, Italy.
2
Pulmonary Unit, Cardiothoracic and Vascular Department, University Hospital of Pisa, Pisa, Italy.
3
Department of Clinical and Experimental Biomedical Sciences, University of Florence.
PMID:
35024679
PMCID:
PMC8733174
DOI:
10.1016/j.lanepe.2021.100300
No abstract available